SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-145650
Filing Date
2023-05-16
Accepted
2023-05-16 07:47:53
Documents
16
Period of Report
2023-05-16
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d471671d8k.htm   iXBRL 8-K 30824
2 EX-99.1 d471671dex991.htm EX-99.1 22107
3 EX-99.2 d471671dex992.htm EX-99.2 4121
7 GRAPHIC g471671ex99_2p1g1.jpg GRAPHIC 716858
8 GRAPHIC g471671g0516023452191.jpg GRAPHIC 631
  Complete submission text file 0001193125-23-145650.txt   1183923

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA coya-20230516.xsd EX-101.SCH 2877
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE coya-20230516_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE coya-20230516_pre.xml EX-101.PRE 11725
10 EXTRACTED XBRL INSTANCE DOCUMENT d471671d8k_htm.xml XML 3469
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41583 | Film No.: 23925590
SIC: 2834 Pharmaceutical Preparations